GSK 37.5 (Paroxetine Extended-Release 37.5 mg)
Pill imprint GSK 37.5 has been identified as Paroxetine hydrochloride extended-release 37.5 mg.
Paroxetine is used in the treatment of anxiety and stress; depression; generalized anxiety disorder; anxiety; dysautonomia (and more), and belongs to the drug class selective serotonin reuptake inhibitors. Excluding Brisdelle: There is positive evidence of human fetal risk during pregnancy. Brisdelle: Not for use in pregnancy. Paroxetine 37.5 mg is not subject to the Controlled Substances Act.
See also related documents.
- 37.5 mg
- Prescription only
X - Not for use in pregnancy - Brisdelle
methacrylic acid - ethyl acrylate copolymer (1:1) type a
sodium lauryl sulfate
More about paroxetine
- Paroxetine capsules
- Paroxetine controlled-release tablets
- Paroxetine mesylate
- Paroxetine suspension
- Paroxetine (Advanced Reading)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2015 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.